A., Alaali, Z., Alnashaba, T., Gasparri, C., Infantino, V., Hammad, L., Riva, A., Petrangolini, G., Allegrini, P., & Rondanelli, M
Schedule a consultation today!
It possible that current B12 deficiency treatment protocols for those with PA are poorly designed and that injections should be much more frequent but of a lower dosage (for example) to more effectively control symptoms
Cagrilintide as a standalone monotherapy is being evaluated in the RENEW Phase 3 program
These symptoms could be due to a deficiency of Vitamin B12
For most patients, the first dose is administered in the week preceding further therapy, with follow-ups every few weeks to help alleviate symptoms and support better health outcomes